China Medicine Corporation (CHME) Demands its Spot in the World’s Pharmaceutical Market
China Medicine Corporation (NASDAQ: CHME) (CMC) was established in 2005 with the goal to become a leading, research-driven pharmaceutical company dedicated to the discovery, development, manufacturing and distribution of pharmaceutical and nutritional supplement products throughout China. To fulfill this mission, CMC acquired Guangzhou Konzern Medicine Co., Ltd. in 2007. Through its wholly-owned subsidiary, Guangzhou Konzern, CMC now distributes about 1,500 pharmaceutical products in the People’s Republic of China to a network of nearly 300 hospitals, 500 pharmaceutical companies and 1,700 drug stores. Not only does the company offer prescription and over-the-counter pharmaceutical products, traditional Chinese medicines, dietary supplements and medical…